REQUEST A DEMO
Total
USD $0.00
Search more companies

Diagnosticos Moleculares S A S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Diagnosticos Moleculares S A S Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Diagnosticos Moleculares S A S is based in Colombia. The head office is in Cota. The company operates in the Diagnostic Imaging Centers industry. The company was established on March 02, 2010. Diagnosticos Moleculares S A S currently employs 1 (2012) people. The latest financial highlights indicate a net sales revenue increase of 38.71% in 2022. Its total assets grew by 135.51% over the same period. Diagnosticos Moleculares S A S’s net profit margin decreased by 1.51% in 2022.

Headquarters
Aut Medellin Km 2.5 Via A Siberia en A Parcelas 900 Mts Ciem Oikos Ba-22
Cota; Cundinamarca;

Contact Details: Purchase the Diagnosticos Moleculares S A S report to view the information.

Basic Information
Total Employees:
Purchase the Diagnosticos Moleculares S A S report to view the information.
Outstanding Shares:
Purchase the Diagnosticos Moleculares S A S report to view the information.
Incorporation Date:
March 02, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Diagnosticos Moleculares S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
38.71%
Total operating revenue
39.45%
Operating profit (EBIT)
73.64%
Net Profit (Loss) for the Period
14.84%
Total assets
135.51%
Total equity
13.49%
Operating Profit Margin (ROS)
3.35%
Net Profit Margin
-1.51%
Return on Equity (ROE)
0.22%
Quick Ratio
-1.97%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?